Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G V Doern

Showing results (151-160 of 169) with videos related to

Pageof 17
Sort By:
Antimicrobial Agents and Chemotherapy|December 3, 1998
In vitro susceptibilities of Candida bloodstream isolates to the new triazole antifungal agents BMS-207147, Sch 56592, and voriconazoleM A Pfaller, S A Messer, R J Hollis, et al.
International Journal of Antimicrobial Agents|April 8, 2000
Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America. SENTRY Participants GroupD J Diekema, M A Pfaller, R N Jones, et al.
American Journal of Obstetrics and Gynecology|October 18, 2000
Group B streptococci causing neonatal bloodstream infection: antimicrobial susceptibility and serotyping results from SENTRY centers in the Western HemisphereJ I Andrews, D J Diekema, S K Hunter, et al.
The Journal of Antimicrobial Chemotherapy|November 1, 1989
Comparison of the safety and efficacy of parenteral ticarcillin/clavulanate and clindamycin/gentamicin in serious intra-abdominal infectionsM P Fink, C M Helsmoortel, E J Arous, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 5, 2002
The molecular epidemiology of penicillin-resistant Streptococcus pneumoniae in the United States, 1994-2000S S Richter, K P Heilmann, S L Coffman, et al.
Diagnostic Microbiology and Infectious Disease|April 23, 1999
Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United StatesM A Pfaller, S A Messer, R J Hollis, et al.
Antimicrobial Agents and Chemotherapy|September 19, 2000
Animal and human multidrug-resistant, cephalosporin-resistant salmonella isolates expressing a plasmid-mediated CMY-2 AmpC beta-lactamaseP L Winokur, A Brueggemann, D L DeSalvo, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 7, 2007
Antimicrobial use in Europe and antimicrobial resistance in Streptococcus pneumoniaeS Riedel, S E Beekmann, K P Heilmann, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2000
Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998M A Pfaller, R N Jones, G V Doern, et al.
Journal of Clinical Microbiology|June 1, 1995
Multicenter clinical laboratory evaluation of a beta-lactamase disk assay employing a novel chromogenic cephalosporin, S1G V Doern, R N Jones, E H Gerlach, et al.
Pageof 17

Showing results (151-160 of 169) with videos related to

Sort By:
Pageof 17
Antimicrobial Agents and Chemotherapy|December 3, 1998
In vitro susceptibilities of Candida bloodstream isolates to the new triazole antifungal agents BMS-207147, Sch 56592, and voriconazoleM A Pfaller, S A Messer, R J Hollis, et al.
International Journal of Antimicrobial Agents|April 8, 2000
Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America. SENTRY Participants GroupD J Diekema, M A Pfaller, R N Jones, et al.
American Journal of Obstetrics and Gynecology|October 18, 2000
Group B streptococci causing neonatal bloodstream infection: antimicrobial susceptibility and serotyping results from SENTRY centers in the Western HemisphereJ I Andrews, D J Diekema, S K Hunter, et al.
The Journal of Antimicrobial Chemotherapy|November 1, 1989
Comparison of the safety and efficacy of parenteral ticarcillin/clavulanate and clindamycin/gentamicin in serious intra-abdominal infectionsM P Fink, C M Helsmoortel, E J Arous, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 5, 2002
The molecular epidemiology of penicillin-resistant Streptococcus pneumoniae in the United States, 1994-2000S S Richter, K P Heilmann, S L Coffman, et al.
Diagnostic Microbiology and Infectious Disease|April 23, 1999
Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United StatesM A Pfaller, S A Messer, R J Hollis, et al.
Antimicrobial Agents and Chemotherapy|September 19, 2000
Animal and human multidrug-resistant, cephalosporin-resistant salmonella isolates expressing a plasmid-mediated CMY-2 AmpC beta-lactamaseP L Winokur, A Brueggemann, D L DeSalvo, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 7, 2007
Antimicrobial use in Europe and antimicrobial resistance in Streptococcus pneumoniaeS Riedel, S E Beekmann, K P Heilmann, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2000
Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998M A Pfaller, R N Jones, G V Doern, et al.
Journal of Clinical Microbiology|June 1, 1995
Multicenter clinical laboratory evaluation of a beta-lactamase disk assay employing a novel chromogenic cephalosporin, S1G V Doern, R N Jones, E H Gerlach, et al.
Pageof 17